Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Lacroix

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2003
PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigenPhilippe Rochaix, Magali Lacroix-Triki, Laurence Lamant, et al.
JCO Precision Oncology|September 14, 2020
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> MutationsBelinda Kingston, Caroline Bailleux, Suzette Delaloge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2025
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trialFrédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2018
Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional casesNadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, et al.
Cancer Research|June 18, 2002
Deregulated DNA polymerase beta induces chromosome instability and tumorigenesisValérie Bergoglio, Marie-Jeanne Pillaire, Magali Lacroix-Triki, et al.
Computers in Biology and Medicine|February 22, 2024
Bias reduction using combined stain normalization and augmentation for AI-based classification of histological imagesCamille Franchet, Robin Schwob, Guillaume Bataillon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2022
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)Florin Dobritoiu, Adelina Baltan, Alina Chefani, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS studyMagali Lacroix-Triki, Simone Mathoulin-Pelissier, Jean-Pierre Ghnassia, et al.
Breast Cancer Research and Treatment|March 10, 2010
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical studyKonstantin J Dedes, Maria-Angeles Lopez-Garcia, Felipe C Geyer, et al.
Breast Cancer Research : BCR|January 24, 2013
RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptorClaire Médale-Giamarchi, Isabelle Lajoie-Mazenc, Emilie Malissein, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2003
PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigenPhilippe Rochaix, Magali Lacroix-Triki, Laurence Lamant, et al.
JCO Precision Oncology|September 14, 2020
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> MutationsBelinda Kingston, Caroline Bailleux, Suzette Delaloge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2025
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trialFrédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2018
Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional casesNadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, et al.
Cancer Research|June 18, 2002
Deregulated DNA polymerase beta induces chromosome instability and tumorigenesisValérie Bergoglio, Marie-Jeanne Pillaire, Magali Lacroix-Triki, et al.
Computers in Biology and Medicine|February 22, 2024
Bias reduction using combined stain normalization and augmentation for AI-based classification of histological imagesCamille Franchet, Robin Schwob, Guillaume Bataillon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2022
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)Florin Dobritoiu, Adelina Baltan, Alina Chefani, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS studyMagali Lacroix-Triki, Simone Mathoulin-Pelissier, Jean-Pierre Ghnassia, et al.
Breast Cancer Research and Treatment|March 10, 2010
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical studyKonstantin J Dedes, Maria-Angeles Lopez-Garcia, Felipe C Geyer, et al.
Breast Cancer Research : BCR|January 24, 2013
RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptorClaire Médale-Giamarchi, Isabelle Lajoie-Mazenc, Emilie Malissein, et al.
Pageof 12